Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.

Moratti M, La Manna M, Colucci L, Cifaldi C, Di Cesare S, Rotulo GA, Rivalta B, Amodio D, Pietrobattista A, Caballero-Oteyza A, Lembo E, Passarelli C, Manno EC, Proietti M, Di Matteo G, Palumbo G, Cancrini C

Open source

DOI: 10.3389/fimmu.2026.1820281
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1820281,
  title = {Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.},
  author = {Moratti M and La Manna M and Colucci L and Cifaldi C and Di Cesare S and Rotulo GA and Rivalta B and Amodio D and Pietrobattista A and Caballero-Oteyza A and Lembo E and Passarelli C and Manno EC and Proietti M and Di Matteo G and Palumbo G and Cancrini C},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1820281},
  url = {https://doi.org/10.3389/fimmu.2026.1820281}
}

RIS

TY  - JOUR
TI  - Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.
AU  - Moratti M
AU  - La Manna M
AU  - Colucci L
AU  - Cifaldi C
AU  - Di Cesare S
AU  - Rotulo GA
AU  - Rivalta B
AU  - Amodio D
AU  - Pietrobattista A
AU  - Caballero-Oteyza A
AU  - Lembo E
AU  - Passarelli C
AU  - Manno EC
AU  - Proietti M
AU  - Di Matteo G
AU  - Palumbo G
AU  - Cancrini C
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1820281
UR  - https://doi.org/10.3389/fimmu.2026.1820281
ER  -

APA

M, M., M, L. M., L, C., C, C., S, D. C., GA, R., B, R., D, A., A, P., A, C., E, L., C, P., EC, M., M, P., G, D. M., G, P., & C, C. (2026). Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1820281

Source records

pubmed · retrieved 2026-11-10T11:32:08.597Z